EMA head forced to step down
This article was originally published in Scrip
Executive Summary
Guido Rasi, executive director of the European Medicines Agency, has had to step down from his position after the EU's civil service tribunal annulled the European Commission's 2011 decision establishing a shortlist of candidates for the post. The judgment means that the decision by the EMA's management board to select Professor Rasi from the shortlist and appoint him executive director on 6 October 2011 has also been annulled.
You may also be interested in...
Industry & Regulators To Align Advice on COVID-19 Vaccine Updates
A multi-stakeholder workshop looked at the data needed to support updates to vaccine composition and the time required by manufacturers to update their vaccines, change their manufacturing processes and prepare approval applications.
Denmark Planning To Impose Drug Stockpiling Obligations From July
A new bill is intended to address the increase in medicine supply problems in Denmark in recent years.
National Drug Stockpiles Create ‘False Sense Of Security’
The generics and biosimilars industry body Medicines for Europe says disparate national stockpiling requirements are not a solution to shortages and can bring “significant risks” for the supply chain and access to medicines.